Co-Diagnostics Inc (NASDAQ:CODX)

4.70
Delayed Data
As of May 16
 +0.15 / +3.30%
Today’s Change
3.66
Today|||52-Week Range
11.82
-47.37%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$155.3M

Company Description

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Contact Information

Co-Diagnostics, Inc.
2401 South Foothill Drive
Salt Lake City Utah 84109
P:(801) 438-1036
Investor Relations:

Employees

Shareholders

Mutual fund holders8.70%
Individual stakeholders7.03%
Other institutional13.02%

Top Executives

Dwight Howard EganChairman, President & Chief Executive Officer
Brian L. BrownChief Financial Officer & Secretary
Jesse MontgomeryChief Scientific Officer
Reed L. BensonGeneral Counsel